Combination Therapies in Bladder Cancer: Insights and Challenges

42 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In part four of this roundtable, Roger Li, MD, Vitaly Margulis, MD, Kyle Rose, MD, and Paul Crispen, MD, debate the potential of combining intravesical immunotherapy with immune checkpoint inhibitors and the evolving role of chemotherapy in BCG-unresponsive disease. The panelists provide insights on emerging data, treatment durability, and practical considerations like patient accessibility and cost, highlighting the complex decision-making landscape for high-risk non-muscle-invasive bladder cancer therapies.

#bladdercancer #bladdercancerawarenessmonth #oncology #cancer #healthcare #urology
Categoria
Oncology
Commenta per primo questo video.

Prossimo